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INTRODUCTION 
Bovine Respiratory Disease, or BRD, are common in young cattle in the first year of life but 
occurs mainly before 6 months. A peak of incidence is noticed between 2-10 weeks, due to a 
decline of immunity. BRD is associated with the well-known shipping-fever that may come 
from cumulative stress. This condition can reach 5-20% case fatality rate and a morbidity 
rate up to 100%. Most of the time, the treatment administered is effective. In other cases, a 
relapse within 2 weeks, associated or not with mortality, can be observed. 
BRD induces economic losses with treatments (antibiotics), prevention (vaccination) and 
mortalities. There are also zootechnical consequences with growth retardation, circulation 
of infectious agents, and increased sensitivity to other pathogens. 
Cattle are more susceptible to BRD for many reasons. They have narrow upper airways that 
increase air speed and allow a deeper colonization of particles in the lower respiratory tract. 
There is also a link between the digestive and respiratory system in bovines. Inhalation of 
eructation gaz occurs regularly. The respiratory tract in cattle is more sensitive to 
endotoxins. In case of rumen acidosis, a paralysis of the mucociliary escalator is observed. 
Finally, cases such liver abscess or Vena Cava Caudale thrombosis, a metastatic pneumonia 
can follow. 
BRD often begins with virus attack, which may be complicated with surroundings bacterial 
infections. Among the different viral aetiologies, Bovine Respiratory Syncytial Virus (B-RSV), 
Parainfluenza virus (PI-3), Bovine Herpes Virus (BHV-1 or IBR), Bovine Viral Diarrhoea Virus 
(BVD, for its immunosuppression effect) are the most frequent encountered. Adenovirus and 
Coronavirus, BHV-4, Rhinovirus, Reovirus, and Enterovirus can also be present, in a lesser 
extent. Among bacteriological causes, Mannheimia haemolytica, Pasteurella multocida, 
Histophilus somni, Trueperella pyogenes, and Mycoplasma bovis (dispar) are commonly met. 
Chlamydophila and Salmonella dublin can sometimes also provoke pneumonias. 
An onset of BRD can begin with only an increased rectal temperature. That is why it is 
recommended to the owner to check for temperature in the different batches of animals. 
After, other symptoms will appear, such as cough, nasal discharge, dyspnea, etc. BRD can be 
categorized in 4 clinical grades, from 1 to 4, according to the severity of the disease. Grade I 
does not need a treatment, as well as grade IV that is so severe that the animal may 
probably die within a few days. Other scores exist and they also take into account symptoms 
 such cough, rectal temperature, nasal discharge, etc. The grade or score of the disease is 
important to establish a treatment, a prognosis or an ancillary exam. Measurement of blood 
L-Lactate (with portable spectrophotometer, e.g. Accutrend-Plus, Cobas, ~150€ and 
~3€/test) allows on the field the determination of the grade of BRD as well as prognosis. L-
Lactate ≥ 4 mmol/L in calves with BRD (up to 13 months) is associated with grade IV BRD and 
poor prognosis (death within 3 days) with 95% sensitivity and 80% specificity (Coghe et al., 
2000). Another study shows that L-Lactate > 3.7 mmol/L is associated with 44 times more 
risk to die in calves with BRD, compared to calves with L-Lactate <1.3 mmol/L (Buczinski et 
al., 2014). 
BRD is clearly a multifactorial disease. Its management must include the resistance of animal 
(genetic, nutrition, vaccination), the environment (ventilation, hygiene) and the 
identification of the infectious agents. This conference is focused on the last topic. 
 
IDENTIFY THE AGENT 
Identify the agent have 4 advantages: establish a diagnosis and prognosis, adapt treatment 
and provide vaccination to prevent troubles. First of all, the complete history of the farm 
must be undertaken, including season, age and origin of infected cattle, previous treatment 
or prophylaxis, previous results in the farm (serologies, necropsies, bacteriology and other 
assays). It is essential to realize new analyses on the farm because the epidemiology of BRD 
can vary according to year, season, and farm. Different ways are available to manage the 
identification of BRD pathogens (see Table 1). 
Table 1: different tools and samples for identification of etiologic agents in BRD animals. 
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serology 








*BAL = Broncho-Alveolar Lavage  **TTA = Trans-Tracheal Aspiration 
1. Cadavers 
Cadaver can be sent to laboratory for necropsy, but the practitioner can conduct it on 
farm to evaluate gross lesions (emphysema, abscess). Some parts of the cadaver (e.g. 
lungs) can be sent to the laboratory for bacteriology or virology. Attention must be 
paid to the quality of cadaver, duration of the disease (acute mortality often 
associated with B-RSV, while chronic disease is more frequently Mycoplasma or BVD) 
and previous treatments administered by the veterinarian or the owner. Antibiotics 
treatments are frequently encountered in cadaver sent to laboratory. Animals 
examined on farm with grade IV BRD, associated with poor prognosis, can be 
 sacrificed prior to any treatment (sentinel animal) in order to go further in the 
etiologic diagnosis. 
 
2. Alive animals 
a. Serology 
Serology is made on serum (blood sampling on plain tube) using an ELISA 
method. In Belgium, B-RSV, PI-3, IBR (gE, gB), Adenovirus, BVD and 
Mycoplasma bovis are available. A single serology is not useful, as this only 
represents a contact with the pathogen and this is no evidence that the 
animal was infected by this pathogen. 
Coupled serologies are more indicative of an active infection. Two blood 
samples (plain tubes) have to be made at 3-4 weeks interval. The first 
sampling must be realised during the acute phase of the disease. A 
multiplication of antibodies (Ab) titles per 2-3 times indicate a 
seroconversion. Samples can be done on treated animals (antibiotics) but not 
on vaccinated animals! 
Limitations of serologies are, among others, the poor seroconversion rate, 
compared to lungs culture (from Broncho-Alveolar Lavage). Prefer this 
analysis at a herd level, in acute phase of BRD. Moreover, for B-RSV, serology 
is sometimes negative after infection (Van der Poel et al., 1997). In presence 
of maternal Ab (from colostrum), there is no or lesser seronconversion with 
usual commercial test (based on IgG fixation) because there is a more 
mucosal response (IgA) rather than humoral (IgG) response (Kimman et al., 
1987). When using coupled serologies, the half-life of Ab must be added to 
the interpretation of the results, as the return to seronegativity can be long: 
3-11 months according to the vaccination status of the animals (Fulton et al., 
2004; Prado et al., 2006). 
 
b. SWABS 
A swab is a small piece of absorbent material attached to the end of a stick 
and used for collecting fluids or secretions in animals. They vary in sizes and 
composition (with/without culture medium, guarded or unguarded). They can 
be used for nasal sampling or naso-pharyngeal sampling (size differs). After 
disinfection of the muzzle, the swab is inserted in the nose for reaching the 
medial part of the eye commissure. Once in the nose, perform a rotation to 
coat the swab with nasal secretions. Put the swab on a culture medium (with 
guarded swabs, there is no culture medium), such as AMIES medium, and 
send immediately to the laboratory. Culture (bacteriology) and antibiogram 
can be performed on swabs, as well as Mycoplasma detection (including PCR) 
and virology (Antigen detection, viral isolation, PCR). 
 Nasal swabs are not predictive of lower respiratory airway pathogens, such 
Mycoplasma (or Mannheimia) (Thomas et al., 2002). Comparing swab and 
BAL, the negative predictive value, meaning the percentage of chance to have 
a negative BAL if swab culture is negative, is 67% and 33%, respectively for 
Mannheimia and Mycoplasma (Godinho et al., 2007). Furthermore, non-
specific subclinical infections can be present in nasal secretions and 
Pasteurella can be existent in nasal cavities of healthy animals (Allan et al., 
1985). Swab is quick, cheap, easy to perform, stressless but less accurate 
compared to BAL/TTA. Swab should be use as a herd diagnosis (take minimum 
10 animals in an infected herd), and not in a single animal. 
 
c. Broncho-Alveolar Lavage (BAL) 
BAL needs a bit more material. A flexible tube (PTFE), with 2x4 mm diameter, 
and of 140 cm length is often used. A needle (14G) is inserted in one 
extremity (for connecting to a syringe). The set must be sterile. Sterile 
syringes and NaCl 0.9% complete the material. For this procedure, head of 
animals must be kept attached up. A disinfection of the muzzle is made and 
the catheter is introduced into the nose, in one movement. The larynx is 
pushed back and the catheter slides deeper. The animal coughs when the 
catheter arrives in the trachea. Thereafter, slide the catheter until blocking at 




 segment of bronchia). Finally, inject NaCl 0.9% 
(preferably at 37°C). The volume depends on the age: 3x60 ml maximum for 
adult cattle and 3x30 ml maximum for calves. After injection of NaCl, directly 
suck back the liquid that will appear foamy and cloudy (40-60% recovered). 
Place this liquid in a plain tube, store at 4°C but preferably send immediately 
to the laboratory. Bacteriology (isolation and/or PCR/ELISA), viral isolation (or 
PCR/ELISA) and cytology (sample on EDTA tube, examined as soon as 
possible) can be made on BAL samples. 
BAL is more contaminated (by nasal cavities) compared to TTA. In some cases, 
the BAL is positive (culture) while TTA is negative. In other cases, less bacteria 
are found in TTA compared to BAL. BAL may not reflect exactly the 
bacteriology pattern of lower respiratory tract (Schreiber et al., 2000). To 
reduce the contamination of upper respiratory tract, a sterile AGAR can be 
used on the extremity of the catheter before introducing into the nasal cavity. 
BAL is indicated for calves (rather that for adult cattle due to the length of 
catheter). 
 
d. Trans-Tracheal Aspiration (TTA) 
TTA is performed using a long sterile intra-catheter (14G, length 600 mm) 
with needle (13G, length 70 mm) (e.g. Centracath, Vygon). The rest of 
material is similar to BAL (NaCl 0.9%, syringes, plain tube). For this procedure, 
 contention is very important. The head of the animal must be held up. A 
surgical preparation of the lower third of ventral neck, front of the trachea, is 
performed (shaving and disinfecting). A local anaesthesia is performed (2 ml 
Procaïne-HCl 4%) and a 5 mm incision is made on the skin, above the trachea 
which should be palpated. The needle is inserted, bevel down, between two 
rings of trachea, perpendicularly first and pushed down thereafter. The 
catheter is then introduced down in the trachea. NaCl is injected (same 
recommendation as for BAL) and recovered (~20% are recovered). Liquid 
obtained is placed into a sterile plain tube and sent immediately to the 
laboratory. Bacteriology (isolation and/or PCR/ELISA), viral isolation (or 
PCR/ELISA) and cytology (sample on EDTA tube, examined as soon as 
possible) can be made on TTA samples. 
TTA should be avoided in calves due to the size of catheter and needle. This 
procedure is more stressful and invasive (calves have small trachea). This 
procedure is reserved for adult cattle, even though it is the most accurate. 
 
e. General remarks for SWABS, BAL and TTA 
Some criteria must be included when selecting an animal for these 
procedures. Table 2 summarizes these conditions. 
 
Table 2: criteria for a successful etiologic diagnosis 
 Animal in acute phase 
 Avoid too severe cases (grade IV BRD) 
 Animals NOT previously treated (antibiotics) 
 Correct (4°C) and rapid (<24h) delivery to the lab 
 
Regarding the storage and delivery of samples, some precautions should be 
observed. For swabs, make sure that the sample is dipped in a culture 
medium (AMIES). Indeed, guarded swabs do not include a culture medium 
(use the culture medium from another unguarded swab). If the sample is not 
directly sent to the lab, store it at 4°C (maximum 7°C). The sample must be 





Immunity depends on multiple factors. Among these, nutrition, maternal immunity, 
vaccination, metaphylaxis, and factors promoting immunosuppression are those on which 
we can act. 
 1. Nutrition 
Energy and protein supply, either for the dams, or for the calves must not be 
neglected. These intakes play a role in maintaining immunity. Trace elements 
(Selenium, Iodine, Copper and Zinc) and vitamins (A, D, E) must also be given in 
adequate amounts. 
 
2. Transfer of colostral immunity (TCI) 
More BRD cases occur when immunity of calves is decreasing (immunity gap). This 
corresponds to the fall of maternal Ab concentration that is not compensated by the 
de novo synthesis of Ab by the calf. The correct transfer of colostral immunity is thus 
of particular importance to keep a good level of Ab in calf’s blood. 
Failure of TCI will get negative outcome on calves’ health. In dairy cattle, a decrease 
of average daily gain and subsequent milk production (1
st
 lactation), as well as an 
increase of mortality and culling (1
st
 lactation), is observed while failure of TCI 
(Robinson et al., 1988; DeNise et al., 1989). In beef cattle, failure of TCI will lead to an 
increased morbidity (especially respiratory troubles), calf mortality (pre-weaning), 
and decreased average daily gain, compared to cattle with correct TCI (Wittum and 
Perino, 1995). Other authors related that blood IgG concentration ≤ 800 mg/dl in 
young calves increase two times the risk of pneumonia. In the same way, 
administration of colostrum from a dam with mastitis increases three times the risk 
of pneumonia in calves (Virtala et al., 1999). It should be noted that increased intakes 
of IgG in calves from a herd with a correct status of TCI will not result in reduction of 
mortality and morbidity. 
There are different ways to assess the success or failure of TCI. Both ways are 
focused on blood sampling in healthy calves at an age between 2 and 6 days of life. 
On the field, there is a semi-quantitative test based on the coagulation of gamma-
globulins with glutaraldehyde (according to the method described by Sandholm, 
1974). The test, developed by the Ambulatory Clinic of the University of Liège (Calf-
IgG-Test) has a Se of about 92% and Sp of 71% (compared to the gold-standard 
Radial-Immuno-Diffusion, unpublished data). A coagulation time within one minute 
assumes an adequate transfer of immunity in the young healthy calf (blood IgG 
concentration >10.1 g/L). In the same way of the assessment of TCI, colostrum 
quality can be measured. A Californian Mastitis test can be first conducted to ensure 
that no subclinical or clinical mastitis is present. On the field, there is also a semi-
quantitative test based on the coagulation of gamma-globulins with glutaraldehyde. 
Fresh colostrum is mixed with a solution of glutaraldehyde and coagulation time is 
noticed. A quick coagulation time indicates a good quality colostrum (> 50 g/L IgG). 
The test is actually under development by the Ambulatory Clinic of the University of 
Liège, with actually similar performances (Se/Sp) compared to Calf-IgG-Test. 
 
 
 3. Vaccination 
Vaccination can be effective in very young cattle (from 2 weeks of life) but, due to 
the presence of Ab from colostrum, interferences may occur. Intra-nasal vaccination 
is thus preferred in these animals. Booster should not be forgotten. A peak of BRD 
often arises in the second half of winter (February-April), due to the higher 
concentration of animals in the barn and the higher infection pressure. It is 
recommended to administer a third injection of vaccine (booster) to calves 
vaccinated a few months earlier to enhance immunity at this period. There are three 
obvious rules for a successful result of vaccination in farms: 
1. Identification of infectious agents 
2. Infectious agent identified is the causative agent of the disease 
3. Vaccine is registered for this infectious agent 
 
4. Metaphylaxis 
Metaphylaxis is a timely mass medication of a group of animals to eliminate or 
minimize an expected outbreak of disease. This procedure should be used with 
caution to avoid unnecessary microbial resistance. This can be recommended at 
batching (on weak animals) or when more than 25% of calves are sick (fever is 




To investigate immunosuppression, the practitioner must check for diseases that may 
affect the immune system. The most known is BVD, but other diseases such as calf 
diarrhoea can predispose the calf to pneumonia. Finally, avoid cumulative stress for 
calves: weaning, dehorning, vaccination, diseases, batching with different ages, mix 
of sick/healthy animals, and overcrowding. 
 
CHANGE ENVIRONMENT 
Last but not least, the environment should be carefully checked for risk factors. The 
ventilation and general hygiene of the barn must be evaluated. The management of the care 
for calves is also a priority. This includes, among others, the care of the umbilicus at birth, 
shearing animals with long hair, and the disinfection of feeding material. 
 
CONCLUSIONS 
The diagnosis of a disease begins with a good history and a correct clinical examination. As 
farms and epidemiology context are different, there is a need to adapt the protocol of 
treatment or prophylaxis (vaccination). For that purpose, there is also a need for 
 identification of pathogens for treatment, metaphylaxis or vaccination. Critical period 
(immunity gap, infectious pressure at 2
nd
 part of winter) should be closely checked by the 
farmer and the veterinarian. The management of BRD requires a multifactorial approach 
including the host (resistance to pathogens), the environment (hygiene, ventilation, 
management) and the infectious agents (virus, bacteria). 
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